Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | ARG2 | P78540 | 4/20 | 0.47 |
| ▸ | ARG1 | P05089 | 3/20 | 0.47 |
| ▸ | NOS2 | P35228 | 5/20 | 0.46 |
| ▸ | NOS1 | P29475 | 4/20 | 0.46 |
| ▸ | NOS3 | P29474 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | OTC | P00480 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9974063 | 1.00 | GSR (0.52) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL21068053 | 1.00 | GSR (0.52) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL29067172 | 0.94 | GSR (0.48) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL30294237 | 0.94 | GSR (0.48) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL3727819 | 0.87 | GSR (0.53) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL28025400 | 0.87 | GSR (0.53) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL1932144 | 0.87 | GSR (0.53) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL457067 | 0.87 | GSR (0.53) | GSRARG2ARG1NOS2NOS1 | |
| Lysine SCHEMBL27593674 | 0.87 | GNAI3 (0.59) | GSRNOD1 | |
| Lysine SCHEMBL28088411 | 0.87 | GNAI3 (0.59) | GSRNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12044684-B2 | Methods for diagnosing an autistic spectrum disorder | QATAR UNIVERSITY (QA) | 2024-07-23 | — | — | US | claimed |
| US-20210033621-A1 | METHODS FOR DIAGNOSING AN AUTISTIC SPECTRUM DISORDER | QATAR UNIVERSITY (QA) | 2021-02-04 | — | — | US | claimed |
| EP-4684030-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-20250170224-A1 | METHODS AND COMPOSITIONS FOR TREATING MICROGLIAL DYSFUNCTION AND IMPROVING METABOLIC DYSFUNCTION | ALBERT-LUDWIGS-UNIVERSITAT FREIBURG (DE) | 2025-05-29 | — | — | US | disclosed |
| WO-2024227957-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2024-11-07 | — | — | WO | disclosed |
| EP-4429657-A1 | METHODS AND COMPOSITIONS FOR TREATING MICROGLIAL DYSFUNCTION AND IMPROVING METABOLIC DYSFUNCTION | Ultimate Medicine AG (CH) | 2024-09-18 | — | — | EP | disclosed |
| US-12044684-B2 | Methods for diagnosing an autistic spectrum disorder | QATAR UNIVERSITY (QA) | 2024-07-23 | — | — | US | disclosed |
| WO-2024018979-A1 | 1,6-HEXANEDIOL COMPOSITION AND POLYMER | DIC株式会社 | 2024-01-25 | — | — | WO | disclosed |
| WO-2024018981-A1 | 1,6-HEXANEDIOL COMPOSITION, POLYMER, CURABLE RESIN COMPOSITION, AND COATING AGENT | DIC株式会社 | 2024-01-25 | — | — | WO | disclosed |
| WO-2024018980-A1 | METHOD FOR PRODUCING 1,6-HEXANE DIOL COMPOSITION, 1,6-HEXANE DIOL COMPOSITION, AND POLYMER | DIC株式会社 | 2024-01-25 | — | — | WO | disclosed |
| WO-2023195378-A1 | CHAIN TRANSFER AGENT, PRODUCTION METHOD OF POLYMER, POLYMER, PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND POLYMER PARTICLES | 国立大学法人信州大学 | 2023-10-12 | — | — | WO | disclosed |
| WO-2003020897-A2 | COMPOSITIONS AND METHODS RELATING TO OVARY SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020934-A1 | COMPOSITIONS AND METHODS RELATING TO COLON SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020899-A2 | COMPOSITIONS AND METHODS RELATING TO LUNG SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| EP-1272843-A2 | METHOD FOR IDENTIFYING REGULATORS OF PROTEIN-AGE FORMATION | Niadyne Corporation (US) | 2003-01-08 | — | — | EP | disclosed |
| US-20020102610-A1 | Automated identification of peptides | OXFORD GLYCOSCIENCES (UK) LTD. (GB) | 2002-08-01 | — | — | US | disclosed |
| US-20020055186-A1 | Detection of peptides | OXFORD GLYCOSCIENCES (UK) LTD. | 2002-05-09 | — | — | US | disclosed |
| US-20020037496-A1 | Method for identifying regulators of protein-advanced glycation end product (protein-AGE) formation | NIADYNE, INC. | 2002-03-28 | — | — | US | disclosed |
| WO-2002025287-A2 | DETECTION OF PEPTIDES | OXFORD GLYCOSCIENCES (UK) LTD. (GB) | 2002-03-28 | — | — | WO | disclosed |
| WO-2001079842-A2 | METHOD FOR IDENTIFYING REGULATORS OF PROTEIN-AGE FORMATION | NIADYNE CORPORATION (US) | 2001-10-25 | — | — | WO | disclosed |